114 results on '"Fabbri, Chiara"'
Search Results
2. The clinical perspective on late-onset depression in European real-world treatment settings
3. Biomarkers of treatment-resistant schizophrenia: A systematic review
4. Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression
5. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
6. Multi-omics data integration methods and their applications in psychiatric disorders
7. Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns
8. COVID-19 hospitalization rates in individuals with substance or alcohol use disorders
9. Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
10. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
11. The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression
12. Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
13. Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study
14. Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder
15. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
16. Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression
17. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies
18. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy
19. Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D
20. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
21. Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank.
22. F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES
23. 67. POLYGENIC RISK SCORES FOR MOOD AND RELATED DISORDERS X ENVIRONMENTAL FACTORS: EFFECTS ON WELLBEING IN THE UK BIOBANK
24. ADVANCING THE GENOMIC PREDICTION OF ANTIDEPRESSANT AND ANTIPSYCHOTIC TREATMENT OUTCOMES
25. 33. SHARED GENETICS LINKING SOCIABILITY WITH THE BRAIN'S DEFAULT MODE NETWORK
26. Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank.
27. UK BIOBANK: A USER GUIDE FOR RESEARCHERS
28. BIG DATA IN DIFFERENT STUDY DESIGNS – ALL WITH THEIR OWN BIASES
29. PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH
30. A GENOME-WIDE META-ANALYSIS OF TREATMENT-RESISTANT DEPRESSION DEFINED USING ELECTRONIC HEALTH RECORDS
31. LOCAL PATTERNS OF SHARED GENETICS AND A GENETIC LATENT FACTOR OF INSULIN RESISTANCE AND NEUROPSYCHIATRIC MULTIMORBIDITY
32. TH30. VITAMIN D AND THE RISK OF TREATMENT-RESISTANT AND ATYPICAL DEPRESSION: A MENDELIAN RANDOMIZATION STUDY
33. W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE
34. W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY
35. 38. LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS
36. TRANSCRIPTOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND DEPRESSION SUBTYPES FOR DRUG REPURPOSING
37. MOVING DEPRESSION PHARMACOGENETICS FORWARD: USING SCIENTIFIC DISCOVERIES TO INFORM CLINICAL DECISIONS
38. M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
39. 57 INVESTIGATING THE COMMON GENETIC BASIS OF ANTIDEPRESSANT RESPONSE
40. 58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA
41. 12 GENETIC UNDERPINNINGS OF SOCIABILITY
42. SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES
43. F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION
44. PHARMACOGENETIC TESTING IN PSYCHIATRY: CRITICAL REVIEW OF EXISTING TESTING KITS AND CLINICAL TRIALS
45. M83 - GENETIC DETERMINANTS OF WEIGHT CHANGE DURING ANTIDEPRESSANT TREATMENT WITH SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS: GENOME-WIDE STUDY AND META-ANALYSIS
46. M38 - GENOME-WIDE ASSOCIATION STUDY OF ANHEDONIA IN GENDEP USING A LINEAR MIXED MODEL IDENTIFIES CANDIDATES WITH RELEVANT BIOLOGICAL FUNCTION
47. SU110 - ROLE OF 108 SCHIZOPHRENIA-ASSOCIATED LOCI IN MODULATING PSYCHOPATOLOGICAL DIMENSIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER
48. SU85 - WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION
49. SA84 - PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE
50. 48 - META-ANALYSIS OF CYP2C19 ASSOCIATION WITH EFFICACY AND SIDE EFFECTS OF CITALOPRAM AND ESCITALOPRAM USING DATA FROM GENOME-WIDE ASSOCIATION STUDIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.